Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Steven Conlan

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Oncotarget|February 27, 2016
Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκBMicaela Morgado, Margie N Sutton, Mary Simmons, et al.
Cancers|August 27, 2021
Hyaluronic Acid-Functionalized Nanomicelles Enhance SAHA Efficacy in 3D Endometrial Cancer ModelsKadie Edwards, Seydou Yao, Simone Pisano, et al.
Frontiers in Endocrinology|October 14, 2024
Corrigendum: Homeobox regulator Wilms Tumour 1 is displaced by androgen receptor at cis-regulatory elements in the endometrium of PCOS patientsDavid W James, Marcos Quintela, Lisa Lucini, et al.
Cell Communication and Signaling : CCS|September 16, 2024
Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancerMichael Ellis Williams, David Howard, Claire Donnelly, et al.
Nanomaterials (Basel, Switzerland)|December 8, 2023
Intracellular Fate of Sub-Toxic Concentration of Functionalized Selenium Nanoparticles in Aggressive Prostate Cancer CellsCaroline Bissardon, Olivier Proux, Salvatore Andrea Gazze, et al.
Frontiers in Oncology|December 12, 2022
Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancerDavid Howard, David James, Jezabel Garcia-Parra, et al.
Redox Biology|February 26, 2023
Selenium nanoparticles modulate histone methylation via lysine methyltransferase activity and S-adenosylhomocysteine depletionBenoit Toubhans, Nour Alkafri, Marcos Quintela, et al.
British Journal of Cancer|April 29, 2023
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancerMarcos Quintela, David W James, Jetzabel Garcia, et al.
Journal of Nanobiotechnology|February 18, 2021
Highly glycosylated MUC1 mediates high affinity L-selectin binding at the human endometrial surfaceLewis W Francis, Seydou N Yao, Lydia C Powell, et al.
Frontiers in Cell and Developmental Biology|February 20, 2025
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasionLydia C Powell, Marcos Quintela, David W James, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Oncotarget|February 27, 2016
Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκBMicaela Morgado, Margie N Sutton, Mary Simmons, et al.
Cancers|August 27, 2021
Hyaluronic Acid-Functionalized Nanomicelles Enhance SAHA Efficacy in 3D Endometrial Cancer ModelsKadie Edwards, Seydou Yao, Simone Pisano, et al.
Frontiers in Endocrinology|October 14, 2024
Corrigendum: Homeobox regulator Wilms Tumour 1 is displaced by androgen receptor at cis-regulatory elements in the endometrium of PCOS patientsDavid W James, Marcos Quintela, Lisa Lucini, et al.
Cell Communication and Signaling : CCS|September 16, 2024
Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancerMichael Ellis Williams, David Howard, Claire Donnelly, et al.
Nanomaterials (Basel, Switzerland)|December 8, 2023
Intracellular Fate of Sub-Toxic Concentration of Functionalized Selenium Nanoparticles in Aggressive Prostate Cancer CellsCaroline Bissardon, Olivier Proux, Salvatore Andrea Gazze, et al.
Frontiers in Oncology|December 12, 2022
Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancerDavid Howard, David James, Jezabel Garcia-Parra, et al.
Redox Biology|February 26, 2023
Selenium nanoparticles modulate histone methylation via lysine methyltransferase activity and S-adenosylhomocysteine depletionBenoit Toubhans, Nour Alkafri, Marcos Quintela, et al.
British Journal of Cancer|April 29, 2023
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancerMarcos Quintela, David W James, Jetzabel Garcia, et al.
Journal of Nanobiotechnology|February 18, 2021
Highly glycosylated MUC1 mediates high affinity L-selectin binding at the human endometrial surfaceLewis W Francis, Seydou N Yao, Lydia C Powell, et al.
Frontiers in Cell and Developmental Biology|February 20, 2025
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasionLydia C Powell, Marcos Quintela, David W James, et al.
Pageof 5